The Meals Study for Amyotrophic Lateral Sclerosis and Parkinson's Disease
NCT07625605 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2026-06-04
Summary
Brief summary template
The goal of this trial is to test the feasibility and efficacy of the Mediterranean-DASH Intervention for Neurodegenerative Delay (the MIND diet) in people living with amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) and healthy controls. The main question\[s\] it aims to answer are:
* How feasibile is our educational dietary intervention, which teaches participants with ALS, PD, and healthy controls to eat by the neuroprotective MIND dietary pattern?
* How does the MIND dietary pattern affect the gut microbiome, metabolome, and lipidome in people with a neurodegenerative disease (ALS or PD) and healthy controls?
* Does the MIND diet affect clinical measures of ALS and PD?
* Does the MIND diet affect human biomarkers of systemic inflammation, metabolism, and neurodegeneration?
Participants will:
* Receive a MIND diet cookbook, a folder with educational handouts, and weekly emails with links to educational videos about the MIND diet.
* Complete a food diary, a MIND diet tracker, and a weekly questionnaire about their experience of eating by the MIND diet.
* Collect stool specimens at the beginning, middle, and end of the study.
* Undergo venipuncture at the beginning and end of the study.
Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Parkinson's Disease (PD)
Interventions
- BEHAVIORAL
-
The MIND diet
Participants meet briefly in person with a study team member to receive study materials (e.g., a MIND diet cookbook, a folder, olive oil, and stool collection kits) and an introduction to the MIND dietary pattern. Instruction includes recognizing the 10 healthy food categories (green leafy vegetables, other vegetables, berries, beans \& legumes, poultry, seafood, whole grains, nuts, wine, and olive oil as the primary oil) and the 5 food categories that are to be limited (sweets, butter/margarine, red meats, eggs, and cheese). Participants receive weekly emails with links to educational videos about the MIND diet, handouts about the MIND diet food categories, serving/portion sizes, and weekly questionnaires. Participants keep food diaries a minimum of three days per week, and complete a daily MIND diet tracker, which reinforces learning the MIND dietary pattern.
Sponsors & Collaborators
-
University of Tennessee
collaborator OTHER -
University of Tennessee Medical Center
collaborator OTHER -
East Tennessee State University
collaborator OTHER -
The University of Tennessee, Knoxville
lead OTHER
Principal Investigators
-
Katherine Hope Morgan, PhD, MSN, FNP-BC, RN · University of Tennessee
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-20
- Primary Completion
- 2025-05-21
- Completion
- 2025-05-21
Countries
- United States
Study Locations
More Related Trials
-
Mediterranean Diet Intervention to Improve Gastrointestinal Function in Parkinson's Disease a Randomized, Controlled, Clinical Trial
NCT04683900 ·Status: COMPLETED ·Phase: NA
-
Dietary Intervention and Gastrointestinal Function in Patients With Parkinson's Disease
NCT03851861 ·Status: COMPLETED ·Phase: NA
-
Determining Patterns In Trial Experiences of Parkinson's Disease Patients
NCT05685329 ·Status: NOT_YET_RECRUITING
-
Treatment of Parkinson's Disease With Eliprodil
NCT00001929 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
NCT00203034 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Cholinergic Augmentation on Measures of Balance and Gait
NCT02206620 ·Status: COMPLETED ·Phase: PHASE2
-
EMD 128130 for the Treatment of Parkinson's Disease
NCT00009048 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease
NCT01603069 ·Status: COMPLETED ·Phase: PHASE2
-
Mediterranean Diet Effects on Parkinson's Disease
NCT06705517 ·Status: RECRUITING ·Phase: NA
-
Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm
NCT02814201 ·Status: COMPLETED
-
Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial
NCT00056563 ·Status: COMPLETED ·Phase: PHASE3
-
Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
NCT01723228 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study
NCT01765257 ·Status: UNKNOWN ·Phase: PHASE4
-
Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease
NCT04449484 ·Status: COMPLETED ·Phase: PHASE1
-
NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
NCT05083260 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Oral Enteral Nutrition Feeding in Parkinson Disease
NCT06303947 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
NCT05709301 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease
NCT03252535 ·Status: COMPLETED ·Phase: PHASE2
-
An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
NCT01215227 ·Status: TERMINATED ·Phase: PHASE3
-
Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
NCT00203060 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
NCT07106021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
NCT00256204 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
NCT00203164 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment
NCT03713957 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Part Trial of CVL-751 in Subjects With Parkinson's Disease
NCT04295642 ·Status: COMPLETED ·Phase: PHASE1